CINECA IRIS Institutional Research Information System

CRUCITTA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.875
AS - Asia 1.997
EU - Europa 1.856
SA - Sud America 348
AF - Africa 174
OC - Oceania 16
Totale 8.266
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.761
IT - Italia 817
SG - Singapore 783
CN - Cina 523
HK - Hong Kong 307
BR - Brasile 298
SE - Svezia 227
DE - Germania 170
GB - Regno Unito 145
VN - Vietnam 100
BG - Bulgaria 94
CI - Costa d'Avorio 92
AT - Austria 73
FR - Francia 69
CA - Canada 62
FI - Finlandia 62
IN - India 51
NL - Olanda 47
PL - Polonia 43
RU - Federazione Russa 43
KR - Corea 40
TR - Turchia 36
JP - Giappone 33
SN - Senegal 29
MX - Messico 23
BD - Bangladesh 19
NG - Nigeria 18
ES - Italia 17
AR - Argentina 16
ID - Indonesia 16
ZA - Sudafrica 12
AU - Australia 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MA - Marocco 9
EC - Ecuador 8
LT - Lituania 8
UA - Ucraina 7
CZ - Repubblica Ceca 6
IL - Israele 6
IQ - Iraq 6
PH - Filippine 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
BE - Belgio 5
KZ - Kazakistan 5
NP - Nepal 5
TW - Taiwan 5
VE - Venezuela 5
CH - Svizzera 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
JO - Giordania 4
KE - Kenya 4
NZ - Nuova Zelanda 4
PA - Panama 4
PE - Perù 4
PK - Pakistan 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CL - Cile 3
CO - Colombia 3
DK - Danimarca 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
LK - Sri Lanka 3
MY - Malesia 3
RO - Romania 3
SV - El Salvador 3
TH - Thailandia 3
AM - Armenia 2
AZ - Azerbaigian 2
BH - Bahrain 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
LV - Lettonia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BM - Bermuda 1
CY - Cipro 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LY - Libia 1
NI - Nicaragua 1
PW - Palau 1
QA - Qatar 1
UG - Uganda 1
Totale 8.266
Salva come PNG Salva come JPEG
Città #
Ashburn 488
Singapore 394
Dallas 392
Santa Clara 315
Hong Kong 303
Fairfield 262
Chandler 211
Woodbridge 164
Houston 163
Shanghai 152
San Jose 146
Seattle 141
Pisa 115
Boardman 113
New York 110
Florence 105
Wilmington 96
Sofia 94
Abidjan 92
London 92
Los Angeles 88
Beijing 84
Cambridge 84
Vienna 67
Serra 59
Milan 58
Munich 56
Princeton 56
Ann Arbor 55
Frankfurt am Main 55
Hefei 51
Lawrence 48
Rome 41
Turin 39
Medford 38
Seoul 35
Warsaw 34
Dakar 29
Istanbul 28
Tokyo 28
Turku 28
Ho Chi Minh City 27
Redondo Beach 27
Ottawa 26
Buffalo 24
São Paulo 23
San Diego 21
Cascina 20
Ogden 19
Helsinki 18
Lagos 18
Dong Ket 16
Nuremberg 15
Dearborn 14
Fuzhou 14
Hanoi 14
Denver 13
Livorno 13
Bremen 12
Chicago 12
Montreal 12
Rio de Janeiro 12
Toronto 12
Washington 12
Brooklyn 11
Chiesina Uzzanese 11
Des Moines 11
San Francisco 11
Boulder 10
Brasília 10
Genoa 10
Lucca 10
Marseille 10
Naples 10
Quanzhou 10
Düsseldorf 9
Lappeenranta 9
Mexico City 9
Nanjing 9
Paris 9
Redwood City 9
Stockholm 9
Belo Horizonte 8
Chennai 8
Guangzhou 8
Johannesburg 8
Tashkent 8
Changsha 7
Columbus 7
Jakarta 7
Mumbai 7
Phoenix 7
Poplar 7
Boston 6
Hyderabad 6
Iowa City 6
Lauterbourg 6
Montevideo 6
San Giuliano Terme 6
Vicopisano 6
Totale 5.704
Salva come PNG Salva come JPEG
Nome #
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC 313
Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer 192
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response 180
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients 180
The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer 179
DPYD*6 plays an important role in fluoropyrimidine toxicity in addition to DPYD*2A and c.2846A>T: a comprehensive analysis in 1254 patients 178
Identification of a targetable KRAS-mutant epithelial population in non-small cell lung cancer 175
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment 171
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer 168
Gene-network analysis predicts clinical response to immunotherapy in patients affected by NSCLC 166
Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management 162
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy 161
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients 160
IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients 156
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. 156
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide 156
Implications of KRAS mutations in acquired resistance to treatment in NSCLC 155
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats 153
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report 150
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases 147
Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression 142
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment 142
Circulating biomarkers of response to immunotherapy in cancer treatment 142
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 141
Comprehensive pharmacogenetic analysis of DPYD, UGT, CDA, and ABCB1 polymorphisms in pancreatic cancer patients receiving mFOLFIRINOX or gemcitabine plus nab-paclitaxel 141
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients 139
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? 139
Gemcitabine plus nab-paclitaxel induces PD-L1 mRNA expression in plasma-derived microvesicles in pancreatic cancer 139
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring 137
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance 134
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC 132
Gene network Analysis Defines a Subgroup of Small Cell Lung Cancer patients With Short Survival 129
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide 129
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy 128
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA 124
Integrating Liquid Biopsy and Radiomics to Monitor Clonal Heterogeneity of EGFR-Positive Non-Small Cell Lung Cancer 124
Incidence of T790M in Patients With NSCLC Progressed to Gefitinib, Erlotinib, and Afatinib: A Study on Circulating Cell-free DNA 123
Erratum: Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers 120
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patients 115
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680–7 113
ErbB in NSCLC as a molecular target: Current evidences and future directions 113
CDK4/6 Inhibitors Overcome Endocrine ESR1 Mutation-Related Resistance in Metastatic Breast Cancer Patients 112
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells 109
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers 106
Reply to comments on: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 105
Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours 104
Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients 104
Pharmacological Basis of Breast Cancer Resistance to Therapies - An Overview 103
Combining liquid biopsy and radiomics for personalized treatment of lung cancer patients. State of the art and new perspectives 103
Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs 101
CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone 101
Concomitant administration of proton pump inhibitors does not significantly affect clinical outcomes in metastatic breast cancer patients treated with ribociclib 100
Androgens alter the heterogeneity of small extracellular vesicles and the small RNA cargo in prostate cancer 97
Expression of Circulating let-7e and miR-126 May Predict Clinical Remission in Patients With Crohn's Disease Treated With Anti-TNF-α Biologics 96
Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients 92
Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Transformation 90
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical Studies 89
β3-adREnoceptor Analysis in CORD Blood of Neonates (β3 RECORD): Study Protocol of a Pilot Clinical Investigation 87
A real-world application of liquid biopsy in metastatic colorectal cancer: The poseidon study 87
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated Acute Myeloid Leukemia (AML) to guide treatment strategy 86
TGF-β mRNA levels in circulating extracellular vesicles are associated with response to anti-PD1 treatment in metastatic melanoma 86
The amount of DNA combined with TP53 mutations in liquid biopsy is associated with clinical outcome of renal cancer patients treated with immunotherapy and VEGFR-TKIs 85
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 76
Recurrent USP6 rearrangement in a subset of atypical myofibroblastic tumours of the soft tissues: low-grade myofibroblastic sarcoma or atypical/malignant nodular fasciitis? 73
Insights from Multigene Panel Sequencing and Comparative Analysis of Metaplastic Carcinoma of the Breast 53
null 15
Artificial intelligence-based pharmacological approach in non-small cell lung cancer in the precision medicine era 6
Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients 3
Concomitant Administration of VEGFR Tyrosine Kinase and Proton Pump Inhibitors May Impair Clinical Outcome of Patients With Metastatic Renal Cancer 3
Totale 8.476
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.819
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.819
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021238 0 0 0 0 0 0 65 12 65 16 32 48
2021/2022523 7 8 6 4 98 98 46 21 33 30 34 138
2022/20231.061 106 136 89 51 92 107 24 75 259 13 99 10
2023/2024809 53 66 123 43 67 147 43 28 20 46 84 89
2024/20252.418 74 72 39 126 254 280 170 144 244 284 284 447
2025/20262.142 273 404 338 390 354 195 188 0 0 0 0 0
Totale 8.476